Global Drug Discovery Technology Market Research Report to 2027 – Multiple Drug Patent Expirations Present Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Drug Discovery Technologies Market Research Report by Technology (Bioanalytical Instruments, Biochips, and Bioinformatics), End User, Region (Americas, Asia-Pacific, and Europe, Middle East, and Africa) – Global Forecast to 2027 – Cumulative impact of COVID-19” report has been added to from ResearchAndMarkets.com offer.
The global drug discovery technology market size was estimated to be USD 55.15 billion in 2021, USD 60.92 billion in 2022, and is projected to grow at a compound annual growth rate (CAGR) of 10.63% for reach USD 101.15 billion by 2027.
Competitive Strategy Window:
The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.
FPNV positioning matrix:
FPNV Positioning Matrix rates and categorizes vendors in the Drug Discovery Technology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Satisfaction product (value for money, ease of use, product features and customer). Support) that helps businesses make better decisions and understand the competitive landscape.
Market share analysis:
The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.
The report provides information about the following pointers:
1. Market Penetration: Provides comprehensive information about the market offered by major players
2. Market Development: Provides detailed information on lucrative emerging markets and analyzes penetration in mature market segments
3. Market Diversification: Provides detailed information on new product launches, untapped geographies, recent developments and investments
4. Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of key players
5. Product Development and Innovation: Provides smart insights into future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the global drug discovery technologies market?
2. What are the inhibiting factors and impact of COVID-19 on the global drug discovery technology market during the forecast period?
3. What are the products/segments/applications/areas to invest in during the forecast period in the global drug discovery technology market?
4. What is the competitive strategic window for opportunities in the Global Drug Discovery Technology Market?
5. What are the technology trends and regulatory frameworks in the global drug discovery technology market?
6. What is the market share of the major vendors in the global drug discovery technology market?
7. What modes and strategic moves are considered suitable for entering the global drug discovery technology market?
Market dynamics
Drivers
-
Increase in disease incidence
-
Increased demand for drugs and biologics due to the benefits, such as highly effective and potent action, and less side effects
-
Increase research and development expenses and investments for the development of new drug molecules
Constraints
-
High initial setup cost for drug discovery and development
-
Need for a long duration of the drug discovery process
Opportunities
-
Expiration of patents on several drugs
-
Advances in biotechnology, molecular biology, nanotechnology and genomics
Challenges
-
Presence of a stringent regulatory environment
Companies cited
-
Abbott Laboratories, Inc.
-
Affymetrix Inc.
-
Agilent Technologies, Inc.
-
Albany Molecular Research Inc.
-
Arqule Inc.
-
Astra Zeneca Plc
-
Bayer Healthcare AG
-
GE Health Ltd.
-
Luminex Corporation
-
Novartis AG
For more information on this report, visit https://www.researchandmarkets.com/r/howrzp